Back to top

Top Ranked Value Stocks to Buy for April 12th

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 12th:

Salem Media Group, Inc. (SALM - Free Report) : This multi-media company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings jumping 20% over the last 60 days.

Salem Media Group’s has a price-to-earnings ratio (P/E) of 14.58, compared with 15.00 for the industry. The company possesses a Value Score of A.

Penske Automotive Group, Inc. (PAG - Free Report) : This transportation services companyhas a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 60 days.

Penske Automotive Group’s has a price-to-earnings ratio (P/E) of 10.61, compared with 66.30 for the industry. The company possesses a Value Score of A.

Unisys Corporation (UIS - Free Report) : This information technology services providerhas a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 0.5% over the last 60 days.

Unisys’s has a price-to-earnings ratio (P/E) of 6.47, compared with 12.90 for the industry. The company possesses a Value Score of A.

ON Semiconductor Corporation (ON - Free Report) : This manufacturer of semiconductor components has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 7.8% over the last 60 days.

ON Semiconductor’s has a price-to-earnings ratio (P/E) of 11.75, compared with 23.70 for the industry. The company possesses a Value Score of A.

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here

5 Trades Could Profit "Big-League" from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>



More from Zacks Zacks #1 Rank Additions

You May Like